Effect of Tobacco Heating System (THS) on Closed Lower Limb Fracture Healing
Evaluation of Tobacco Heating System (THS) Compared to Conventional Cigarette Smoking During the Closed Lower Limb (Tibia and Femur) Fracture Healing in Orthopedic Smokers' Patients
1 other identifier
interventional
150
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed lower limb (tibia and femur) fractures from smokers' orthopedic patients. Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2023
CompletedFirst Posted
Study publicly available on registry
May 16, 2023
CompletedStudy Start
First participant enrolled
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2026
CompletedDecember 11, 2024
December 1, 2024
2.4 years
March 30, 2023
December 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)
Marker collagen formation - bone formation
6 months after tibia fracture surgery
Secondary Outcomes (18)
Concentration of Alkaline Phosphatase (BAP)
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Osteoprogesterin
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Osteopontin
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of N-terminal telopeptide (NTx)
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Interleukin 1 beta (IL-1β)
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
- +13 more secondary outcomes
Other Outcomes (15)
Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1)
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of High densitiy lipoprotein cholesterol levels (HDL)
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Leucocytes
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
- +12 more other outcomes
Study Arms (3)
Smokers
NO INTERVENTIONParticipants subject to an orthopedic surgery (does not want to quit smoking conventional cigarettes) will continue smoking conventional cigarettes ad libitum for a period of 6 month post surgery
Smokers willing to switch to THS
EXPERIMENTALParticipants subject to an orthopedic surgery (currently smoking conventional cigarettes) will start to used THS ad libitum for a period of 6 month post surgery
Ex Smokers
ACTIVE COMPARATORParticipants subject to an orthopedic surgery will not smoke cigarettes or use electronic nicotine deliver systems for a period of 6 month post surgery
Interventions
Participant who are not willing to quit cigarette smoking during the study duration will switch from cigarettes to using THS
Participant who are willing to quit cigarette smoking and will not use any electronic nicotine delivery system during the study duration
Eligibility Criteria
You may qualify if:
- Closed tibia or femur fracture (according to AO/OTA: 41A2-41C3, 42A-C, 43A-C, 32A-C, 33A2-3, 33B-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen.
- Smokers with 10-20 packyears smoking history.
- Smoking history \>10 years.
- Decision not to participate in the free smoking cessation seminars.
You may not qualify if:
- Legal guardian or loss of capacity to consent.
- Refusal to participate in the study.
- Open fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication.
- Initial surgical treatment of the fracture has occurred ex domo.
- No initial surgical treatment within 14 days of sustained trauma.
- Using nicotine delivery electronic devices.
- Pre-existing autoimmune, immunological, bone or malignant diseases.
- Pregnant, breastfeeding and women of childbearing age with existing desire to have children.
- History of alcohol abuse or drug abuse.
- Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM).
- Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- Philip Morris Products S.A.collaborator
Study Sites (1)
Siegfried Weller Institutes, BG-Trauma Clinic, Department of Traumatology, Eberhard Karls University Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
Related Publications (3)
Aspera-Werz RH, Ehnert S, Muller M, Zhu S, Chen T, Weng W, Jacoby J, Nussler AK. Assessment of tobacco heating system 2.4 on osteogenic differentiation of mesenchymal stem cells and primary human osteoblasts compared to conventional cigarettes. World J Stem Cells. 2020 Aug 26;12(8):841-856. doi: 10.4252/wjsc.v12.i8.841.
PMID: 32952862BACKGROUNDWeng W, Bovard D, Zanetti F, Ehnert S, Braun B, Uynuk-Ool T, Histing T, Hoeng J, Nussler AK, Aspera-Werz RH. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023 Mar;173:113637. doi: 10.1016/j.fct.2023.113637. Epub 2023 Jan 25.
PMID: 36708864BACKGROUNDMoritz Herbst, Romina Aspera-Werz, Benedikt Braun, Kevin Schulz, et al. (2024). Evaluation of the Tobacco Heating System (THS) During Closed Lower Limb Fracture Healing in Trauma Smokers' Patients. Qeios. doi:10.32388/DE0EAE.2.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesor Doctor
Study Record Dates
First Submitted
March 30, 2023
First Posted
May 16, 2023
Study Start
June 2, 2023
Primary Completion
October 15, 2025
Study Completion
April 17, 2026
Last Updated
December 11, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 months after results are published in peer-reviewed international journal
All IPD (in an anonymous form) that underlie results in a publication